Parameters affecting the drug release from in situ gelling nasal inserts
The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, dip...
Saved in:
Published in | European journal of pharmaceutics and biopharmaceutics Vol. 63; no. 3; pp. 310 - 319 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.07.2006
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug–polymer interactions (formation of less soluble drug–polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na
+-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug–polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug–polymer interactions and by the composition of the release medium. |
---|---|
AbstractList | The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug-polymer interactions (formation of less soluble drug-polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na+-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug-polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug-polymer interactions and by the composition of the release medium. The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug release from in situ gelling nasal inserts. Sponge-like nasal inserts of carrageenan and HPMC K15M with the model drugs oxymetazoline HCl, diprophyllin, and acetaminophen (APAP) were prepared by lyophilization. Drug release studies at different drug loadings were performed in various release media. Raman analysis, DSC, and SEM were conducted to analyze the physical state of the drugs in the inserts. All drugs were dissolved in the solid HPMC inserts and were released at similar rates at all investigated loadings except for the least soluble APAP. APAP concentrations in the hydrating HPMC K15M inserts in excess of its solubility limit resulted in reduced relative release rates at higher drug loadings. Drug–polymer interactions (formation of less soluble drug–polymer salts) resulted in a slower release of oxymetazoline HCl from carrageenan inserts than from HPMC K15M inserts. Changes in the composition of the release medium affected the water uptake of carrageenan but not of HPMC K15M inserts. Oxymetazoline release from carrageenan inserts increased with higher Na +-content of the medium because of ion exchange and at low (pH 2) as well as at high pH (pH 10). The osmolality of the release medium had no effect. The solubility of the drug, its physical state in the polymer matrix, and drug–polymer interactions governed the drug release from nasal inserts. The release from inserts prepared with oppositely charged polymers and drugs was influenced by electrostatic drug–polymer interactions and by the composition of the release medium. |
Author | Bertram, Ulrike Bodmeier, Roland |
Author_xml | – sequence: 1 givenname: Ulrike surname: Bertram fullname: Bertram, Ulrike – sequence: 2 givenname: Roland surname: Bodmeier fullname: Bodmeier, Roland email: bodmeier@zedat.fu-berlin.de |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17878183$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16513333$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1r3DAQhkXY0uwm_QM9FF_amx2NZa9k6KWEthsIpIfkLGRptNHij63GDvTfR2YX9ta5DAzP-zI8G7YaxgEZ-wy8AA7bu0OBh2NblJzXBUDBubpia1BS5KKqYMXWvBFNvq0ArtmG6MA5r2StPrJr2NYg0qzZ7o-JpscJI2XGe7RTGPbZ9IqZi_M-i9ihIcx8HPssDBmFac722HULNRgyXboSxolu2QdvOsJP533DXn79fL7f5Y9Pvx_ufzzmVqhqym1lOShA05Q1lLIRWJWNaJ011oNDJ4WVdemddKK0TQteVCXUVjjbeuk8iBv27dR7jOPfGWnSfSCbPjIDjjPpreIgleIJLE-gjSNRRK-PMfQm_tPA9eJPH_TiTy_-NIBO_lLoy7l9bnt0l8hZWAK-ngFD1nQ-msEGunBSSQVq4b6fOEwu3gJGTTbgYNGFmCRrN4b__fEO9cSQZA |
CitedBy_id | crossref_primary_10_1208_s12249_013_9956_y crossref_primary_10_1155_2013_958465 crossref_primary_10_1016_j_ijpharm_2008_02_025 crossref_primary_10_2166_wst_2016_362 crossref_primary_10_1007_s12034_014_0697_7 crossref_primary_10_1208_s12249_014_0171_2 crossref_primary_10_1039_C5RA27785J crossref_primary_10_1016_j_jddst_2015_11_004 crossref_primary_10_1016_j_carbpol_2016_07_075 crossref_primary_10_3109_03639045_2011_598536 crossref_primary_10_1080_03602559_2016_1253734 crossref_primary_10_1155_2013_139864 crossref_primary_10_1002_polb_21549 crossref_primary_10_1002_smtd_202301726 crossref_primary_10_53879_id_60_10_12854 crossref_primary_10_1016_j_msec_2016_03_091 crossref_primary_10_1016_j_chroma_2009_10_050 crossref_primary_10_1080_00914037_2013_830257 |
Cites_doi | 10.1164/ajrccm.160.2.9805117 10.1016/S0169-409X(97)00063-X 10.1016/S0168-3659(01)00389-3 10.1016/S0939-6411(01)00135-7 10.1177/000348949810700109 10.1295/polymj.14.181 10.1016/S1773-2247(04)50048-5 10.1016/S0378-5173(01)00930-9 10.1023/A:1013330815253 10.1172/JCI119802 10.1016/S0264-410X(01)00188-8 10.1016/S0378-5173(99)00442-1 10.1164/ajrccm/137.3.625 10.1016/0378-5173(95)00070-Y |
ContentType | Journal Article |
Copyright | 2005 Elsevier B.V. 2006 INIST-CNRS |
Copyright_xml | – notice: 2005 Elsevier B.V. – notice: 2006 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ejpb.2005.11.008 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3441 |
EndPage | 319 |
ExternalDocumentID | 10_1016_j_ejpb_2005_11_008 16513333 17878183 S0939641105003139 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SES SEW SPCBC SSP SSU SSZ T5K TEORI UNMZH ~G- ABPIF ABPTK IQODW AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c384t-c4c0181ea92512793e4293bdcacf1ded73c752fd7d32c9b1f34215c3dcbf7df13 |
IEDL.DBID | .~1 |
ISSN | 0939-6411 |
IngestDate | Fri Oct 25 02:31:38 EDT 2024 Thu Sep 26 17:27:41 EDT 2024 Sat Sep 28 07:41:26 EDT 2024 Sun Oct 22 16:10:05 EDT 2023 Fri Feb 23 02:28:03 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Nasal drug delivery Release medium Drug–polymer interaction Inserts Carrageenan Extended drug release HPMC Drug Pharmaceutical technology Controlled release form In situ Polymer Intranasal administration Insert Dosage form Drug interaction Drug-polymer interaction Release |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c384t-c4c0181ea92512793e4293bdcacf1ded73c752fd7d32c9b1f34215c3dcbf7df13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16513333 |
PQID | 68017880 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_68017880 crossref_primary_10_1016_j_ejpb_2005_11_008 pubmed_primary_16513333 pascalfrancis_primary_17878183 elsevier_sciencedirect_doi_10_1016_j_ejpb_2005_11_008 |
PublicationCentury | 2000 |
PublicationDate | 2006-07-01 |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 2006-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | European journal of pharmaceutics and biopharmaceutics |
PublicationTitleAlternate | Eur J Pharm Biopharm |
PublicationYear | 2006 |
Publisher | Elsevier B.V Elsevier Science |
Publisher_xml | – name: Elsevier B.V – name: Elsevier Science |
References | Sachdeva, Sachdeva, Gulati, Kakkar (bib12) 1993; 98 Behl, Pimplaskar, Sileno, deMeireles, Romeo (bib17) 1998; 29 Merkus, Verhoef (bib4) 1994; vol. 10 Junginger, Verhoef, Merkus (bib9) 1991; 131 Washington, Steele, Jackson, Bush, Mason, Gill, Pitt, Rawlins (bib10) 2000; 198 Teshima, Yamauchi, Makino, Kataoka, Arita, Nawata, Oishi (bib8) 2002; 233 Puttipipatkhachorn, Nunthanid, Ymamoto, Peck (bib18) 2001; 75 Togias, Proud, Lichtenstein, Adams, Norman, Kagey-Sobotka, Naclerio (bib13) 1988; 137 Hercules Inc., GENU Majima, Harada, Shimizu, Takeuchi, Sakakura, Yoshinaga (bib16) 1999; 160 McInnes, Thapa, Stevens, Baillie, Watson, Nolan, Gibson (bib3) 2000 Oh, Kim, Hwang, Ko, Kim, Yang, Kim (bib6) 2001; 19 Akahane, Kawashima, Hirao, Shimizu, Minakata (bib19) 1982; 14 Pereswetoff-Morath, Edman (bib7) 1995; 124 J. Berendes, R. Link, F. Zöllner, Hals-Nasen-Ohren-Heilkunde in Praxis und Klinik: Obere und untere Luftwege, I. Thieme-Verlag, Stuttgart, Chapters 2, 10, 11, 16 (1977). Atsuta, Majima (bib15) 1998; 107 Gupta, Hariharan, Wheatley, Price (bib20) 2001; 51 Knowles, Robinson, Wood, Pue, Mentz, Wager, Gatzy, Boucher (bib14) 1997; 100 R. Bodmeier, P. Maincent, Zubereitungen mit verlängerter Verweildauer am Applikationsort, German Patent DE 197 56 314 A 1, 1999. carrageenan – general description. Product information, 1997. Werner, Damgé, Maincent, Bodmeier (bib2) 2004; 14 Ahsan, Arnold, Meezan, Pillion (bib5) 2001; 18 10.1016/j.ejpb.2005.11.008_bib11 10.1016/j.ejpb.2005.11.008_bib21 Akahane (10.1016/j.ejpb.2005.11.008_bib19) 1982; 14 Atsuta (10.1016/j.ejpb.2005.11.008_bib15) 1998; 107 Werner (10.1016/j.ejpb.2005.11.008_bib2) 2004; 14 Oh (10.1016/j.ejpb.2005.11.008_bib6) 2001; 19 Majima (10.1016/j.ejpb.2005.11.008_bib16) 1999; 160 Ahsan (10.1016/j.ejpb.2005.11.008_bib5) 2001; 18 Pereswetoff-Morath (10.1016/j.ejpb.2005.11.008_bib7) 1995; 124 Teshima (10.1016/j.ejpb.2005.11.008_bib8) 2002; 233 10.1016/j.ejpb.2005.11.008_bib1 Washington (10.1016/j.ejpb.2005.11.008_bib10) 2000; 198 Togias (10.1016/j.ejpb.2005.11.008_bib13) 1988; 137 McInnes (10.1016/j.ejpb.2005.11.008_bib3) 2000 Junginger (10.1016/j.ejpb.2005.11.008_bib9) 1991; 131 Sachdeva (10.1016/j.ejpb.2005.11.008_bib12) 1993; 98 Puttipipatkhachorn (10.1016/j.ejpb.2005.11.008_bib18) 2001; 75 Behl (10.1016/j.ejpb.2005.11.008_bib17) 1998; 29 Merkus (10.1016/j.ejpb.2005.11.008_bib4) 1994; vol. 10 Knowles (10.1016/j.ejpb.2005.11.008_bib14) 1997; 100 Gupta (10.1016/j.ejpb.2005.11.008_bib20) 2001; 51 |
References_xml | – volume: 100 start-page: 2588 year: 1997 end-page: 2596 ident: bib14 article-title: Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects publication-title: J. Clin. Invest. contributor: fullname: Boucher – volume: 131 start-page: 295 year: 1991 end-page: 303 ident: bib9 article-title: Nasal Arzneiformen für die systemische Wirkstoffabsorption publication-title: Dtsch. Apoth. Ztg. contributor: fullname: Merkus – volume: 14 start-page: 181 year: 1982 end-page: 188 ident: bib19 article-title: Ion selectivities of some extracellular viscous polysaccharides from red algae publication-title: Polymer J. (Tokyo, Japan) contributor: fullname: Minakata – volume: 198 start-page: 139 year: 2000 end-page: 146 ident: bib10 article-title: Determination of baseline human nasal pH and the effect of intranasally administered buffers publication-title: Int. J. Pharm. contributor: fullname: Rawlins – volume: 19 start-page: 4519 year: 2001 end-page: 4525 ident: bib6 article-title: Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery publication-title: Vaccine contributor: fullname: Kim – volume: 107 start-page: 47 year: 1998 end-page: 51 ident: bib15 article-title: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus publication-title: Ann. Otol. Rhinol. Laryngol. contributor: fullname: Majima – volume: 137 start-page: 625 year: 1988 end-page: 629 ident: bib13 article-title: The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air publication-title: Am. Rev. Respir. Dis. contributor: fullname: Naclerio – volume: 14 start-page: 275 year: 2004 end-page: 284 ident: bib2 article-title: Properties of in situ gelling nasal insert containing estradiol/methyl β-cyclodextrin publication-title: J. Drug Del. Sci. Technol. contributor: fullname: Bodmeier – volume: vol. 10 start-page: 191 year: 1994 end-page: 220 ident: bib4 article-title: Nasal drug delivery: trends and perspectives publication-title: Encyclopedia of Pharmaceutical Technology contributor: fullname: Verhoef – volume: 98 start-page: 265 year: 1993 end-page: 268 ident: bib12 article-title: Nasal mucociliary clearance and mucus pH in patients with diabetes mellitus publication-title: Indian J. Med. Res. contributor: fullname: Kakkar – volume: 51 start-page: 241 year: 2001 end-page: 248 ident: bib20 article-title: Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Price – volume: 75 start-page: 143 year: 2001 end-page: 153 ident: bib18 article-title: Drug physical state and drug–polymer interaction on drug release from chitosan matrix films publication-title: J. Contr. Rel. contributor: fullname: Peck – volume: 18 start-page: 1742 year: 2001 end-page: 1746 ident: bib5 article-title: Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats publication-title: Pharm. Res. contributor: fullname: Pillion – volume: 233 start-page: 61 year: 2002 end-page: 66 ident: bib8 article-title: Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers publication-title: Int. J. Pharm. contributor: fullname: Oishi – volume: 124 start-page: 37 year: 1995 end-page: 44 ident: bib7 article-title: Dextran microspheres as a potential nasal drug delivery system for insulin – in vitro and in vivo properties publication-title: Int. J. Pharm. contributor: fullname: Edman – start-page: 2121 year: 2000 ident: bib3 article-title: Nasal absorption of nicotine in sheep from a lyophilised insert formulation publication-title: AAPS Ann. Meeting contributor: fullname: Gibson – volume: 160 start-page: 421 year: 1999 end-page: 426 ident: bib16 article-title: Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis publication-title: Am. J. Respir. Crit. Care Med. contributor: fullname: Yoshinaga – volume: 29 start-page: 89 year: 1998 end-page: 116 ident: bib17 article-title: Effects of physicochemical properties and other factors on systemic nasal drug delivery publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Romeo – volume: 160 start-page: 421 year: 1999 ident: 10.1016/j.ejpb.2005.11.008_bib16 article-title: Effect of biochemical components on rheologic properties of nasal mucus in chronic sinusitis publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/ajrccm.160.2.9805117 contributor: fullname: Majima – volume: 29 start-page: 89 year: 1998 ident: 10.1016/j.ejpb.2005.11.008_bib17 article-title: Effects of physicochemical properties and other factors on systemic nasal drug delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00063-X contributor: fullname: Behl – volume: 75 start-page: 143 year: 2001 ident: 10.1016/j.ejpb.2005.11.008_bib18 article-title: Drug physical state and drug–polymer interaction on drug release from chitosan matrix films publication-title: J. Contr. Rel. doi: 10.1016/S0168-3659(01)00389-3 contributor: fullname: Puttipipatkhachorn – volume: 51 start-page: 241 issue: 3 year: 2001 ident: 10.1016/j.ejpb.2005.11.008_bib20 article-title: Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/S0939-6411(01)00135-7 contributor: fullname: Gupta – ident: 10.1016/j.ejpb.2005.11.008_bib21 – volume: 107 start-page: 47 issue: 1 year: 1998 ident: 10.1016/j.ejpb.2005.11.008_bib15 article-title: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus publication-title: Ann. Otol. Rhinol. Laryngol. doi: 10.1177/000348949810700109 contributor: fullname: Atsuta – start-page: 2121 issue: Suppl. 2 year: 2000 ident: 10.1016/j.ejpb.2005.11.008_bib3 article-title: Nasal absorption of nicotine in sheep from a lyophilised insert formulation publication-title: AAPS Ann. Meeting contributor: fullname: McInnes – volume: 14 start-page: 181 issue: 3 year: 1982 ident: 10.1016/j.ejpb.2005.11.008_bib19 article-title: Ion selectivities of some extracellular viscous polysaccharides from red algae publication-title: Polymer J. (Tokyo, Japan) doi: 10.1295/polymj.14.181 contributor: fullname: Akahane – volume: 14 start-page: 275 issue: 4 year: 2004 ident: 10.1016/j.ejpb.2005.11.008_bib2 article-title: Properties of in situ gelling nasal insert containing estradiol/methyl β-cyclodextrin publication-title: J. Drug Del. Sci. Technol. doi: 10.1016/S1773-2247(04)50048-5 contributor: fullname: Werner – volume: 233 start-page: 61 year: 2002 ident: 10.1016/j.ejpb.2005.11.008_bib8 article-title: Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(01)00930-9 contributor: fullname: Teshima – volume: 18 start-page: 1742 issue: 12 year: 2001 ident: 10.1016/j.ejpb.2005.11.008_bib5 article-title: Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats publication-title: Pharm. Res. doi: 10.1023/A:1013330815253 contributor: fullname: Ahsan – volume: 100 start-page: 2588 issue: 10 year: 1997 ident: 10.1016/j.ejpb.2005.11.008_bib14 article-title: Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects publication-title: J. Clin. Invest. doi: 10.1172/JCI119802 contributor: fullname: Knowles – volume: 19 start-page: 4519 year: 2001 ident: 10.1016/j.ejpb.2005.11.008_bib6 article-title: Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery publication-title: Vaccine doi: 10.1016/S0264-410X(01)00188-8 contributor: fullname: Oh – volume: vol. 10 start-page: 191 year: 1994 ident: 10.1016/j.ejpb.2005.11.008_bib4 article-title: Nasal drug delivery: trends and perspectives contributor: fullname: Merkus – volume: 198 start-page: 139 year: 2000 ident: 10.1016/j.ejpb.2005.11.008_bib10 article-title: Determination of baseline human nasal pH and the effect of intranasally administered buffers publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(99)00442-1 contributor: fullname: Washington – volume: 131 start-page: 295 issue: 8 year: 1991 ident: 10.1016/j.ejpb.2005.11.008_bib9 article-title: Nasal Arzneiformen für die systemische Wirkstoffabsorption publication-title: Dtsch. Apoth. Ztg. contributor: fullname: Junginger – ident: 10.1016/j.ejpb.2005.11.008_bib11 – volume: 137 start-page: 625 issue: 3 year: 1988 ident: 10.1016/j.ejpb.2005.11.008_bib13 article-title: The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air publication-title: Am. Rev. Respir. Dis. doi: 10.1164/ajrccm/137.3.625 contributor: fullname: Togias – volume: 124 start-page: 37 year: 1995 ident: 10.1016/j.ejpb.2005.11.008_bib7 article-title: Dextran microspheres as a potential nasal drug delivery system for insulin – in vitro and in vivo properties publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)00070-Y contributor: fullname: Pereswetoff-Morath – ident: 10.1016/j.ejpb.2005.11.008_bib1 – volume: 98 start-page: 265 issue: 3 year: 1993 ident: 10.1016/j.ejpb.2005.11.008_bib12 article-title: Nasal mucociliary clearance and mucus pH in patients with diabetes mellitus publication-title: Indian J. Med. Res. contributor: fullname: Sachdeva |
SSID | ssj0004758 |
Score | 1.9836173 |
Snippet | The purpose of the study was to investigate the influence of physicochemical drug properties, drug loading, and composition of the release medium on the drug... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 310 |
SubjectTerms | Administration, Intranasal Biological and medical sciences Carrageenan Carrageenan - administration & dosage Delayed-Action Preparations - chemistry Drug–polymer interaction Extended drug release Gels - chemistry General pharmacology HPMC Hydrogen-Ion Concentration Hypromellose Derivatives Inserts Medical sciences Methylcellulose - administration & dosage Methylcellulose - analogs & derivatives Nasal drug delivery Nasal Mucosa - metabolism Osmolar Concentration Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Release medium Solubility Static Electricity |
Title | Parameters affecting the drug release from in situ gelling nasal inserts |
URI | https://dx.doi.org/10.1016/j.ejpb.2005.11.008 https://www.ncbi.nlm.nih.gov/pubmed/16513333 https://search.proquest.com/docview/68017880 |
Volume | 63 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EL4KIb9fHmoN40bq2SV_HRVxWRVlQwVvJq1IPdbG7By_-dmealiKoB68hIWEmmW-SzHwDcIwgnCLQWM_YhFJyYuMlaWC9JL8ItUxVGEnKd767j8ZP4uY5fF6AyzYXhsIqG9vvbHptrZuWQSPNwbQoBg94F08jgfAV1gSElMQnEP5wT59_dmEeIq5rdFJnj3o3iTMuxsu-TpV7VyEmTyox-TM4rUxlhSLLXa2L353RGpRGa7DaeJNs6Ba8Dgu23ICTiaOj_jhjj112VXXGTtikI6r-2ITxRFJoFvFrMlnHdSCOMfQImXmfvzAqp4IYxygDhRUlq4rZnL3YmsSblbLCiYuSPvOrLXgaXT1ejr2msoKneSJmnhaaiLqsTMm9wSNqEZa4Mlrq3DfWxFzHYZCb2PBAp8rPuUDXQHOjVR6b3OfbsFi-lXYXmFR5KmJtVGqtCAMlhQyMz6WI8OKYRH4PTluRZlNHoJG1kWWvGSmAKmGGeBPJUAE9CFupZ9-2QYYW_s9x_W8q6qZCg4Q-Ce_BUauzDA8Q_YrI0r7NqyxCjI7RivVgx6myGxtR8RvO9_65qH1Ydg82FNx7AIuz97k9RBdmpvr1Hu3D0vD6dnz_BSy48J4 |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7R7aGVUNUXZUsBHyouJWwTOw8fEWK1bQGt1EXiZvmVVTiEFdk9cOlv70ycKEJqOXCNHNny2PN9tme-AfiKICwRaHzkfEEpObmLCpn4qCi_p1ZLk2aa8p0vr7LZtfh5k95swVmfC0NhlZ3vDz699dbdl0k3m5NVVU1-41lcZgLhK20FCOULeCmIH-OiPvkzxHmIvC3SSa0jat5lzoQgL3-7MuFihaQ8qcbkv9Fpe6UbnLMyFLv4PxttUWn6Ft50dJKdhhG_gy1fv4ejedCjfjhmiyG9qjlmR2w-KFU_fIDZXFNsFglsMt0GdiCQMaSEzN1vlozqqSDIMUpBYVXNmmq9YUvfqnizWjfYcVXTa37zEa6n54uzWdSVVogsL8Q6ssKSUpfXkvgN7lGPuMSNs9qWsfMu5zZPk9LljidWmrjkArmB5c6aMndlzHdgVN_VfheYNqUUuXVGei_SxGihExdzLTI8ORZZPIZv_ZSqVVDQUH1o2a0iA1ApzBSPIgoNMIa0n3X1aB0odPFP_nfwyERDV-iRkJTwMRz2NlO4g-hZRNf-btOoDEE6Rzc2hk_BlMO_GVW_4fzzMwd1CK9mi8sLdfHj6tcevA63NxTp-wVG6_uN30c-szYH7Xr9C85Q8jc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Parameters+affecting+the+drug+release+from+in+situ+gelling+nasal+inserts&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Bertram%2C+Ulrike&rft.au=Bodmeier%2C+Roland&rft.date=2006-07-01&rft.issn=0939-6411&rft.volume=63&rft.issue=3&rft.spage=310&rft_id=info:doi/10.1016%2Fj.ejpb.2005.11.008&rft_id=info%3Apmid%2F16513333&rft.externalDocID=16513333 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon |